ONYX HEALTHCARE INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 165 TWD | +0.30% |
|
-1.49% | -4.07% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 2,601 | 3,455 | 3,576 | 3,162 | 3,253 | 5,763 |
| Enterprise Value (EV) 1 | 1,896 | 3,057 | 3,188 | 3,285 | 3,109 | 5,592 |
| P/E ratio | 13.4 x | 14.5 x | 21.5 x | 24.9 x | 15.8 x | 22.7 x |
| Yield | 5% | 3.82% | 4.23% | 3.83% | 5.11% | 2.91% |
| Capitalization / Revenue | 1.83 x | 2.33 x | 2.65 x | 2.63 x | 2.03 x | 3.86 x |
| EV / Revenue | 1.33 x | 2.06 x | 2.37 x | 2.73 x | 1.94 x | 3.75 x |
| EV / EBITDA | 9.72 x | 12.2 x | 18.3 x | 36.2 x | 19 x | 23.7 x |
| EV / FCF | 21.2 x | 10.9 x | 28.8 x | -10.2 x | 177 x | 33.7 x |
| FCF Yield | 4.71% | 9.18% | 3.47% | -9.81% | 0.57% | 2.97% |
| Price to Book | 2.86 x | 3.43 x | 3.43 x | 3.08 x | 2.34 x | 3.81 x |
| Nbr of stocks (in thousands) | 30,261 | 30,261 | 30,261 | 30,261 | 33,261 | 33,506 |
| Reference price 2 | 85.95 | 114.2 | 118.2 | 104.5 | 97.80 | 172.0 |
| Announcement Date | 2/27/19 | 3/2/20 | 3/15/21 | 3/4/22 | 2/23/23 | 3/1/24 |
1TWD in Million2TWD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 1,425 | 1,483 | 1,347 | 1,202 | 1,600 | 1,493 |
| EBITDA 1 | 195.1 | 251.3 | 174.4 | 90.84 | 163.6 | 235.9 |
| EBIT 1 | 181.7 | 236.6 | 160.7 | 74.51 | 145.4 | 218.1 |
| Operating Margin | 12.75% | 15.96% | 11.92% | 6.2% | 9.09% | 14.61% |
| Earnings before Tax (EBT) 1 | 227.9 | 289.9 | 202.6 | 140.1 | 242 | 305 |
| Net income 1 | 194.9 | 239.4 | 167.1 | 127.6 | 203 | 255.3 |
| Net margin | 13.68% | 16.14% | 12.4% | 10.61% | 12.68% | 17.1% |
| EPS 2 | 6.400 | 7.869 | 5.491 | 4.200 | 6.200 | 7.590 |
| Free Cash Flow 1 | 89.35 | 280.5 | 110.7 | -322.1 | 17.56 | 165.9 |
| FCF margin | 6.27% | 18.92% | 8.21% | -26.8% | 1.1% | 11.11% |
| FCF Conversion (EBITDA) | 45.81% | 111.63% | 63.45% | - | 10.73% | 70.32% |
| FCF Conversion (Net income) | 45.84% | 117.19% | 66.24% | - | 8.65% | 65% |
| Dividend per Share 2 | 4.298 | 4.364 | 5.000 | 4.000 | 4.996 | 5.000 |
| Announcement Date | 2/27/19 | 3/2/20 | 3/15/21 | 3/4/22 | 2/23/23 | 3/1/24 |
1TWD in Million2TWD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | 123 | - | - |
| Net Cash position 1 | 705 | 398 | 388 | - | 144 | 171 |
| Leverage (Debt/EBITDA) | - | - | - | 1.349 x | - | - |
| Free Cash Flow 1 | 89.3 | 281 | 111 | -322 | 17.6 | 166 |
| ROE (net income / shareholders' equity) | 21.3% | 24.2% | 15.9% | 12.1% | 16.7% | 17.5% |
| ROA (Net income/ Total Assets) | 9.73% | 11.4% | 7.24% | 3.01% | 4.95% | 6.79% |
| Assets 1 | 2,003 | 2,091 | 2,306 | 4,239 | 4,097 | 3,759 |
| Book Value Per Share 2 | 30.00 | 33.30 | 34.50 | 33.90 | 41.80 | 45.10 |
| Cash Flow per Share 2 | 7.350 | 13.50 | 13.00 | 6.040 | 9.890 | 10.90 |
| Capex 1 | 19.4 | 8.82 | 11.3 | 295 | 12 | 67.6 |
| Capex / Sales | 1.36% | 0.59% | 0.84% | 24.53% | 0.75% | 4.53% |
| Announcement Date | 2/27/19 | 3/2/20 | 3/15/21 | 3/4/22 | 2/23/23 | 3/1/24 |
1TWD in Million2TWD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -4.07% | 171M | |
| +7.93% | 219B | |
| +7.53% | 183B | |
| +15.20% | 136B | |
| +27.02% | 107B | |
| -1.14% | 63.07B | |
| +7.23% | 52.55B | |
| +12.58% | 51.28B | |
| +1.61% | 41.21B | |
| +5.32% | 36.43B |
- Stock Market
- Equities
- 6569 Stock
- Financials Onyx Healthcare Inc.